• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Laninamivir-[13C,15N2]

General Information
Catalog: BLP-000788
Molecular Formula: C12[13C]H22N2[15N]2O7
Molecular Weight: 349.32
Chemical Structure
Laninamivir-[13C,15N2]
Description Laninamivir-[13C,15N2] is the labelled analogue of Laninamivir. Laninamivir is a new potent neuraminidase (NA) inhibitor. It has been used in trials studying the treatment of Influenza.
Synonyms [13C,15N2]-Laninamivir; (4S,5R,6R)-5-Acetamido-4-carbamimidamido-6-((1R,2R)-3-hydroxy-2-methoxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic Acid-13C,15N2; (4S,5R,6R)-5-Acetamido-4-guanidino-6-((1R,2R)-2,3-dihydroxy-1-methoxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic Acid-13C,15N2; R 125489-13C,15N2; 5-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-7-O-methyl-D-glycero-D-galacto-non-2-enonic Acid-13C,15N2
IUPAC Name (2R,3R,4S)-3-acetamido-4-((di(amino-15N)methylene-13C)amino)-2-((1R,2R)-2,3-dihydroxy-1-methoxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
Related CAS 203120-17-6 (unlabelled)
Purity 98%

Interested in our Service & Products?
Need detailed information?

USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: info@bocsci.com
  • Fax: 1-631-614-7828
UK
  • 44-20-3286-1088
  • 85 Great Portland Street, London, W1W 7LT
  • Email: info@bocsci.com
Copyright © 2025 BOC Sciences. All Rights Reserved.
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x